Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
603.58
-2.03 (-0.34%)
May 5, 2025, 4:00 PM EDT - Market closed

Regeneron Pharmaceuticals Statistics

Total Valuation

REGN has a market cap or net worth of $63.78 billion. The enterprise value is $48.86 billion.

Market Cap 63.78B
Enterprise Value 48.86B

Important Dates

The last earnings date was Tuesday, April 29, 2025, before market open.

Earnings Date Apr 29, 2025
Ex-Dividend Date May 20, 2025

Share Statistics

REGN has 105.67 million shares outstanding. The number of shares has increased by 0.13% in one year.

Current Share Class 103.85M
Shares Outstanding 105.67M
Shares Change (YoY) +0.13%
Shares Change (QoQ) -2.28%
Owned by Insiders (%) 3.64%
Owned by Institutions (%) 91.01%
Float 101.65M

Valuation Ratios

The trailing PE ratio is 15.31 and the forward PE ratio is 16.80. REGN's PEG ratio is 2.66.

PE Ratio 15.31
Forward PE 16.80
PS Ratio 4.61
Forward PS 4.20
PB Ratio 2.18
P/TBV Ratio 2.26
P/FCF Ratio 20.56
P/OCF Ratio 16.13
PEG Ratio 2.66
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.93, with an EV/FCF ratio of 15.75.

EV / Earnings 10.86
EV / Sales 3.47
EV / EBITDA 10.93
EV / EBIT 12.29
EV / FCF 15.75

Financial Position

The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.09.

Current Ratio 4.93
Quick Ratio 3.90
Debt / Equity 0.09
Debt / EBITDA 0.60
Debt / FCF 0.87
Interest Coverage 83.17

Financial Efficiency

Return on equity (ROE) is 15.96% and return on invested capital (ROIC) is 8.04%.

Return on Equity (ROE) 15.96%
Return on Assets (ROA) 6.91%
Return on Invested Capital (ROIC) 8.04%
Return on Capital Employed (ROCE) 11.70%
Revenue Per Employee $932,457
Profits Per Employee $297,849
Employee Count 15,106
Asset Turnover 0.39
Inventory Turnover 2.44

Taxes

In the past 12 months, REGN has paid $484.90 million in taxes.

Income Tax 484.90M
Effective Tax Rate 9.73%

Stock Price Statistics

The stock price has decreased by -36.93% in the last 52 weeks. The beta is 0.43, so REGN's price volatility has been lower than the market average.

Beta (5Y) 0.43
52-Week Price Change -36.93%
50-Day Moving Average 633.36
200-Day Moving Average 837.06
Relative Strength Index (RSI) 50.94
Average Volume (20 Days) 1,246,821

Short Selling Information

The latest short interest is 2.60 million, so 2.46% of the outstanding shares have been sold short.

Short Interest 2.60M
Short Previous Month 2.79M
Short % of Shares Out 2.46%
Short % of Float 2.56%
Short Ratio (days to cover) 2.38

Income Statement

In the last 12 months, REGN had revenue of $14.09 billion and earned $4.50 billion in profits. Earnings per share was $39.43.

Revenue 14.09B
Gross Profit 6.87B
Operating Income 3.98B
Pretax Income 4.78B
Net Income 4.50B
EBITDA 4.47B
EBIT 3.98B
Earnings Per Share (EPS) $39.43
Full Income Statement

Balance Sheet

The company has $8.35 billion in cash and $2.70 billion in debt, giving a net cash position of $14.92 billion or $141.21 per share.

Cash & Cash Equivalents 8.35B
Total Debt 2.70B
Net Cash 14.92B
Net Cash Per Share $141.21
Equity (Book Value) 29.39B
Book Value Per Share 277.50
Working Capital 14.01B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $3.95 billion and capital expenditures -$851.30 million, giving a free cash flow of $3.10 billion.

Operating Cash Flow 3.95B
Capital Expenditures -851.30M
Free Cash Flow 3.10B
FCF Per Share $29.35
Full Cash Flow Statement

Margins

Gross margin is 48.80%, with operating and profit margins of 28.22% and 31.94%.

Gross Margin 48.80%
Operating Margin 28.22%
Pretax Margin 35.38%
Profit Margin 31.94%
EBITDA Margin 31.74%
EBIT Margin 28.22%
FCF Margin 22.02%

Dividends & Yields

This stock pays an annual dividend of $1.76, which amounts to a dividend yield of 0.29%.

Dividend Per Share $1.76
Dividend Yield 0.29%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 4.46%
Buyback Yield -0.13%
Shareholder Yield 0.16%
Earnings Yield 7.05%
FCF Yield 4.86%
Dividend Details

Analyst Forecast

The average price target for REGN is $907.39, which is 50.34% higher than the current price. The consensus rating is "Buy".

Price Target $907.39
Price Target Difference 50.34%
Analyst Consensus Buy
Analyst Count 23
Revenue Growth Forecast (5Y) 7.22%
EPS Growth Forecast (5Y) 13.58%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

REGN has an Altman Z-Score of 9.55 and a Piotroski F-Score of 3.

Altman Z-Score 9.55
Piotroski F-Score 3